Zobrazeno 1 - 10
of 335
pro vyhledávání: ''
Autor:
Haibo Ding, Lin Wang, Zhen Wang, Minghui An, Bin Zhao, Xiaoxu Han, Lu Wang, Xin Li, Wei Song, Xue Dong, Wen Tian
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Metho
Autor:
Fernando Achinelli, Gerardo Andino, Maria Bangher, Paola Itati Reynoso, Antonia Cristina Aquino, Jorge Ojeda, Silvana Dellamea, Victor Flores, María Gabriela Aguirre, Elba Meza, Carolina N. Martemucci, Pablo Kawerin, Fabian Plano, Mariana Elizabeth Robledo, Claudia Campias, Hector Andres Guglielmone, Noelia Carolina Sosa, Evangelina Chaparro Campias, Rodrigo Zoni, Maria Mercedes Vernengo, Silvina Maria Martinez, Joaquina Maria Guarrochena, Natalia E. Ruiz Diaz, Diego Farizano Salazar, Julio Vallejos, Maria Fernanda Medina, Angelina Bobadilla, Silvina Villamandos, Juan Emanuel Segovia
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. Objective
Autor:
Grahame Mtui, Semvua B. Kilonzo, Paulina M. Manyiri, Daniel W. Gunda, Fredrick Kalokola, Elichilia R. Shao, Fatma A. Bakshi, Hyasinta Jaka, Alex Stephano, David C. Majinge
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Methadone therapy clinics have been recently introduced in Tanzania, aiming at reducing risk behaviors and infection rates of viral hepatitis and HIV among people who use drugs. The objective of this study was to estimate the prevalence, a
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Antibiotic-resistance reduces the efficacy of conventional triple therapy for Helicobacter Pylori infections worldwide, which necessitates using various treatment protocols. We used two protocols, doxycycline-based quadruple regimen and co
Autor:
Daniel Golparian, Tatyana Golubovskaya, Iryna Boiko, Magnus Unemo, Aliaksandra Aniskevich, Iryna Stanislavova, Aliaksandr Adaskevich, Iryna Shimanskaya, Susanne Jacobsson
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Limited antimicrobial resistance (AMR) data for Neisseria gonorrhoeae are available in Eastern Europe. We investigated AMR in N. gonorrhoeae isolates in the Republic of Belarus from 2009 to 2019, antimicrobial treatment recommended nationa
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Carbapenem-resistant Enterobacter cloacae complex (CREC) is a new emerging threat to global public health. The objective of the study was to investigate the clinical characteristics and molecular epidemiology of CREC infections in the medi
Autor:
Ayşegül Karalezli, Nurullah Okumuş, Fatma Eser, Rıza Aytaç Çetinkaya, Semiha Orhan, İsmail Yaşar Avcı, Neşe Demirtürk, Umit Savasci, Bengü Şaylan, Levent Yamanel, Petek Konya, Gürhan Taşkin, Rahmet Guner, Bircan Kayaaslan, Gulden Yilmaz
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background and objectives An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness in treatment has been
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Lower respiratory tract infection is a global problem accounting over 50 million deaths annually. Here, we determined the bacterial profile and antimicrobial susceptibility pattern of lower respiratory tract infections among adult patients
Autor:
Edmund Wilkins, Frank Smithuis, Alistair R. D. McLean, Clare E. Warrell, Catriona Macrae, Ni Ni Tun, Elizabeth A. Ashley
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Cryptococcal meningitis (CM) is a common HIV-associated opportunistic-infection worldwide. Existing literature focusses on hospital-based outcomes of induction treatment. This paper reviews outpatient management in integrated primary care
Autor:
Martín Soñora, Daniela Chiodi, Pablo López, Juan Cristina, Pilar Moreno, Natalia Echeverría, Fabián Aldunate, Gonzalo Moratorio, Nelia Hernández, Adriana Sánchez-Cicerón
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
COLIBRI
Universidad de la República
instacron:Universidad de la República
BMC Infectious Diseases
COLIBRI
Universidad de la República
instacron:Universidad de la República
BMC Infectious Diseases
Background Direct-Acting agents (DAAs) target and inhibit essential viral replication proteins. They have revolutionized the treatment of Hepatitis C virus (HCV) infection reaching high levels of sustained virologic response. However, the detection o